<DOC>
	<DOCNO>NCT01539902</DOCNO>
	<brief_summary>The efficacy measure hUC-MSC treatment proliferative lupus nephritis remission lupus nephritis ( combine partial complete remission ) term stabilization improvement renal function .</brief_summary>
	<brief_title>Phase 2 Study Human Umbilical Cord Derived Mesenchymal Stem Cell Treatment Lupus Nephritis</brief_title>
	<detailed_description>Inclusion criterion : 1 . Male non-pregnant female age 16 65 year inclusive . 2 . Written inform consent obtain patient parents/guardian . 3 . Patients SLE fulfilling American Rheumatism Association criterion SLEDAI score &gt; 8 BILAG score A/B . 4 . Patients newly diagnose World Health Organization ( WHO ) Class III IV Lupus Nephritis .</detailed_description>
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Lupus Nephritis</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<criteria>1 . Male nonpregnant female age 16 65 year inclusive . 2 . Written inform consent obtain patient parents/guardian . 3 . Patients SLE fulfilling American Rheumatism Association criterion SLEDAI score &gt; 8 BILAG score A/B . 4 . Patients newly diagnose World Health Organization ( WHO ) Class III IV Lupus Nephritis Patients follow eligible enrollment study : 1 . Pregnant nursing woman woman childbearing potential except postmenopausal , surgically sterile use accepted method ( ) birth control negative pregnancy test . 2 . Participation research patient receive investigational product within 30 day precede screen phase study . 3 . Those person directly involve conduct study . 4 . Serum creatinine 250 Âµmol/L . 5 . White blood cell ( WBC ) count le 3.5 X 109/L . 6 . Active peptic ulcer disease . 7 . Active systemic infection . 8 . History alcohol substance abuse . 9 . History malignancy within previous 5 year . 10 . Any serious medical condition disability , opinion investigator , would interfere treatment assessment preclude completion study .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>MSC treatment Lupus Nephritis</keyword>
</DOC>